Inflammatory Bowel Disease News and Research

RSS
Inflammatory bowel disease (IBD) is an ongoing or chronic health problem that causes inflammation and swelling in the digestive tract. The irritation causes bleeding sores called ulcers to form along the digestive tract. This in turn can cause crampy, abdominal pain and severe bloody diarrhea.

There are two main types of inflammatory bowel disease: ulcerative colitis (UC) and Crohn's disease (CD). The diseases are very similar. In fact, doctors often have a hard time figuring out which type of IBD a person has. The main difference between UC and CD is the area of the digestive tract they affect. CD can occur along the entire digestive tract and spread deep into the bowel wall. In contrast, UC usually only affects the top layer of the large intestine (colon) and rectum. Medicine can control the symptoms of IBD in most women. But for people who have severe IBD, surgery is sometimes needed. Over the course of a person's life, the symptoms of IBD often come and go. With close monitoring and medicines, most people with IBD lead full and active lives.
FDA approves Tysabri to treat Crohn's disease

FDA approves Tysabri to treat Crohn's disease

Il-22 gene delivers the goods and decreases intestinal inflammation

Il-22 gene delivers the goods and decreases intestinal inflammation

ACG offers updated clinical guidance for managing pregnant patients

ACG offers updated clinical guidance for managing pregnant patients

Discovery of new signaling molecule could lead to the development of new treatments for cancer

Discovery of new signaling molecule could lead to the development of new treatments for cancer

New insight into ulcerative colitis

New insight into ulcerative colitis

Threshold for colectomy may be too high, warn experts

Threshold for colectomy may be too high, warn experts

Clinical threshold for inflammatory bowel disease surgery may be too high

Clinical threshold for inflammatory bowel disease surgery may be too high

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients

New understanding of vagus nerve's role in regulating inflammation

New understanding of vagus nerve's role in regulating inflammation

Discovery of two genes linked to a disabling form of arthritis called ankylosing spondylitis

Discovery of two genes linked to a disabling form of arthritis called ankylosing spondylitis

New analyses of long-term LIALDA (mesalamine) data presented at ACG

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients

Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients

Specific immune deficiency pinpointed as likely cause of ulcerative colitis

Specific immune deficiency pinpointed as likely cause of ulcerative colitis

Key to colon cancer prevention is regular screenings

Key to colon cancer prevention is regular screenings

Colonoscopy most effective screening option for colon cancer

Colonoscopy most effective screening option for colon cancer

Clostridium difficile infection is four times more likely to kill patients with inflammatory bowel disease

Clostridium difficile infection is four times more likely to kill patients with inflammatory bowel disease

LL37 peptide provides a new potential target for autoimmune disease

LL37 peptide provides a new potential target for autoimmune disease

Have you ever experienced pain in your abdomen?

Have you ever experienced pain in your abdomen?

New treatment to combat bowel infection among the elderly

New treatment to combat bowel infection among the elderly

Biologic agents valuable treatment option for patients with inflammatory bowel disease

Biologic agents valuable treatment option for patients with inflammatory bowel disease